CorMedix (CRMD) Cash from Operations (2010 - 2025)

CorMedix (CRMD) has 15 years of Cash from Operations data on file, last reported at 94461181.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Operations rose 1782.34% year-over-year to 94461181.0; the trailing twelve-month figure through Dec 2025 stood at 175046000.0 (up 445.84% YoY), and the FY2025 full-year result was 175046000.0, up 445.84% from the prior year.
• Cash from Operations advanced to 94461181.0 in Q4 2025, from 30856502.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 94461181.0 in Q4 2025 to a low of 17310294.0 in Q1 2024.
• A 5-year average of 2025478.25 and a median of 6075137.5 in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations tumbled 309.81% in 2021 and surged 1782.34% in 2025, its largest moves.
• Tracing CRMD's Cash from Operations over 5 years: stood at 5869360.0 in 2021, then retreated by 4.86% to 6154839.0 in 2022, then plunged by 74.59% to 10745694.0 in 2023, then jumped by 47.75% to 5614883.0 in 2024, then surged by 1782.34% to 94461181.0 in 2025.
• Business Quant data shows CRMD's Cash from Operations at 94461181.0 in Q4 2025, 30856502.0 in Q3 2025, and 29991814.0 in Q2 2025.